Page last updated: 2024-08-21

c.i. 42510 and Inflammatory Breast Cancer

c.i. 42510 has been researched along with Inflammatory Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akay, CL; Babiera, GV; DeSnyder, SM; Krishnamurthy, S; Kuerer, HM; Le-Petross, C; Lucci, A; Mittendorf, EA; Ueno, NT; Whitman, GJ; Woodward, WA; Yang, W	1

Trials

1 trial(s) available for c.i. 42510 and Inflammatory Breast Cancer

Article	Year
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clinical breast cancer, 2018, Volume: 18, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Negative Reactions; Feasibility Studies; Female; Humans; Inflammatory Breast Neoplasms; Lymphatic Metastasis; Mastectomy, Simple; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Period; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium; Treatment Outcome; Ultrasonography	2018

Article

Year

Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.

Clinical breast cancer, 2018, Volume: 18, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Negative Reactions; Feasibility Studies; Female; Humans; Inflammatory Breast Neoplasms; Lymphatic Metastasis; Mastectomy, Simple; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Period; Prospective Studies; Rosaniline Dyes; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium; Treatment Outcome; Ultrasonography

2018